Two Cases of H2-Receptor Antagonist Hypersensitivity and Cross-Reactivity

被引:18
作者
Song, Woo-Jung [1 ,2 ]
Kim, Min-Hye [1 ,2 ]
Lee, Sang-Min [3 ]
Kwon, Yong-Eun [4 ]
Kim, Sae-Hoon [1 ,2 ,5 ]
Cho, Sang-Heon [1 ,2 ]
Min, Kyung-Up [1 ,2 ]
Kim, You-Young [1 ,2 ]
Chang, Yoon-Seok [1 ,2 ,5 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[2] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul 151, South Korea
[3] Armed Forces Capital Hosp, Dept Internal Med, Songnam, South Korea
[4] Chosun Univ, Coll Med, Dept Internal Med, Kwangju, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam 463802, South Korea
关键词
Histamine H-2 receptor antagonists; cross reactions; drug hypersensitivity; allergy; ANAPHYLACTIC REACTION; RANITIDINE; FAMOTIDINE; NIZATIDINE; SAFETY;
D O I
10.4168/aair.2011.3.2.128
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
H-2-receptor antagonists, such as cimetidine, ranitidine and famotidine, are some of the most commonly prescribed medications for gastric acid-related disorders. These compounds are generally well-tolerated and anaphylactic reactions to them are rare. Here, we report two cases of H-2-receptor antagonist-induced anaphylactic reactions: the first presented with sudden dyspnea, sneezing, urticaria, and swelling of the eyelids after ranitidine intake. The second presented with sudden severe urticaria, facial swelling, chest discomfort, dizziness, and hypotension. Possible cross-reactivity with other H-2-receptor antagonists was assessed by oral challenge and skin tests. To date, only a few reports addressing cross-reactivity among H-2-receptor antagonists have been published. We review the literature and summarize the data available on drug cross-reactivity in H-2-receptor antagonist hypersensitivity.
引用
收藏
页码:128 / 131
页数:4
相关论文
共 14 条
[1]   SIDE-EFFECTS, STRUCTURE, AND H-2-RECEPTOR ANTAGONISTS [J].
BOSSI, A ;
ROMEO, G ;
PEZZOLI, A .
LANCET, 1992, 339 (8805) :1366-1366
[2]  
Demirkan K, 2006, J INVEST ALLERG CLIN, V16, P203
[3]  
Howden CW, 1996, CLIN THER, V18, P36
[4]  
HOWDEN CW, 1996, CLIN THER, V18, P35
[5]  
Kim YI, 2010, J INVEST ALLERG CLIN, V20, P166
[6]   Ranitidine-induced anaphylaxis: detection of serum specific IgE antibody [J].
Koh, YI ;
Park, HS ;
Choi, IS .
ALLERGY, 2006, 61 (02) :269-270
[7]   ANAPHYLACTIC REACTION TO RANITIDINE [J].
LAZARO, M ;
COMPAIRED, JA ;
DELAHOZ, B ;
IGEA, JM ;
MARCOS, C ;
DAVILA, I ;
LOSADA, E .
ALLERGY, 1993, 48 (05) :385-387
[8]  
Levine M, 1998, J PHARMACOL EXP THER, V284, P493
[9]   The safety of ranitidine in over a decade of use [J].
Mills, JG ;
Koch, KM ;
Webster, C ;
Sirgo, MA ;
Fitzgerald, K ;
Wood, JR .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) :129-137
[10]   Nizatidine anaphylaxis [J].
MiraPerceval, JL ;
Ortiz, JL ;
Sarrio, F ;
Miralles, JC ;
Hernandez, J ;
NegroAlvarez, JM ;
LopezSanchez, JD ;
GarciaSelles, FJ ;
Pagan, JA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (03) :855-856